医学
观察研究
他汀类
药方
内科学
入射(几何)
随机对照试验
癌症
肝硬化
肝癌
重症监护医学
药理学
光学
物理
作者
Carlos Moctezuma‐Velázquez,Juan G. Abraldeṣ
标识
DOI:10.14309/ajg.0000000000001385
摘要
Abstract Several observational studies have shown an association between statin use and lower incidence of liver cancer. However, several potential biases limit a causal interpretation that could lead to a recommendation of statin prescription to patients with cirrhosis in the absence of a cardiovascular indication. Ongoing randomized trials will soon provide a clearer picture on the efficacy and safety of statins for preventing liver cancer and other complications of cirrhosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI